Urologix Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Urologix's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Mar 2015 |
Recent past performance updates
No updates
Recent updates
No updates
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Urologix has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Show sectionRevenue & Expenses BreakdownBeta
How Urologix makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 15 | 12 | -5 | 5 | 1 |
| 31 Dec 14 | 13 | -6 | 6 | 1 |
| 30 Sep 14 | 13 | -7 | 7 | 2 |
| 30 Jun 14 | 14 | -8 | 8 | 2 |
| 31 Mar 14 | 15 | -5 | 9 | 2 |
| 31 Dec 13 | 16 | -5 | 10 | 2 |
| 30 Sep 13 | 16 | -5 | 10 | 2 |
| 30 Jun 13 | 16 | -4 | 10 | 2 |
Quality Earnings: Insufficient data to determine if ULGX has high quality earnings.
Growing Profit Margin: Insufficient data to determine if ULGX's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ULGX's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare ULGX's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if ULGX's earnings growth over the past year exceeded the Medical Equipment industry average.
Return on Equity
High ROE: ULGX has a negative Return on Equity (0%), as it is currently unprofitable.